位置:首页 > 蛋白库 > ERG4A_ASPFU
ERG4A_ASPFU
ID   ERG4A_ASPFU             Reviewed;         471 AA.
AC   Q4WW43;
DT   23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 1.
DT   03-AUG-2022, entry version 67.
DE   RecName: Full=Delta(24(24(1)))-sterol reductase erg4A {ECO:0000303|PubMed:27986720};
DE            EC=1.3.1.71 {ECO:0000305|PubMed:16110826};
DE   AltName: Full=C-24(28) sterol reductase erg4A {ECO:0000303|PubMed:27986720};
DE   AltName: Full=Ergosterol biosynthesis protein 4A {ECO:0000303|PubMed:16110826};
DE   AltName: Full=Sterol Delta(24(28))-reductase erg4A {ECO:0000303|PubMed:27986720};
GN   Name=erg4A {ECO:0000303|PubMed:27986720}; ORFNames=AFUA_5G14350;
OS   Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC
OS   A1100) (Aspergillus fumigatus).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC   Aspergillus subgen. Fumigati.
OX   NCBI_TaxID=330879;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100;
RX   PubMed=16372009; DOI=10.1038/nature04332;
RA   Nierman W.C., Pain A., Anderson M.J., Wortman J.R., Kim H.S., Arroyo J.,
RA   Berriman M., Abe K., Archer D.B., Bermejo C., Bennett J.W., Bowyer P.,
RA   Chen D., Collins M., Coulsen R., Davies R., Dyer P.S., Farman M.L.,
RA   Fedorova N., Fedorova N.D., Feldblyum T.V., Fischer R., Fosker N.,
RA   Fraser A., Garcia J.L., Garcia M.J., Goble A., Goldman G.H., Gomi K.,
RA   Griffith-Jones S., Gwilliam R., Haas B.J., Haas H., Harris D.E.,
RA   Horiuchi H., Huang J., Humphray S., Jimenez J., Keller N., Khouri H.,
RA   Kitamoto K., Kobayashi T., Konzack S., Kulkarni R., Kumagai T., Lafton A.,
RA   Latge J.-P., Li W., Lord A., Lu C., Majoros W.H., May G.S., Miller B.L.,
RA   Mohamoud Y., Molina M., Monod M., Mouyna I., Mulligan S., Murphy L.D.,
RA   O'Neil S., Paulsen I., Penalva M.A., Pertea M., Price C., Pritchard B.L.,
RA   Quail M.A., Rabbinowitsch E., Rawlins N., Rajandream M.A., Reichard U.,
RA   Renauld H., Robson G.D., Rodriguez de Cordoba S., Rodriguez-Pena J.M.,
RA   Ronning C.M., Rutter S., Salzberg S.L., Sanchez M., Sanchez-Ferrero J.C.,
RA   Saunders D., Seeger K., Squares R., Squares S., Takeuchi M., Tekaia F.,
RA   Turner G., Vazquez de Aldana C.R., Weidman J., White O., Woodward J.R.,
RA   Yu J.-H., Fraser C.M., Galagan J.E., Asai K., Machida M., Hall N.,
RA   Barrell B.G., Denning D.W.;
RT   "Genomic sequence of the pathogenic and allergenic filamentous fungus
RT   Aspergillus fumigatus.";
RL   Nature 438:1151-1156(2005).
RN   [2]
RP   IDENTIFICATION, FUNCTION, AND PATHWAY.
RX   PubMed=16110826; DOI=10.1080/13693780400029114;
RA   Ferreira M.E., Colombo A.L., Paulsen I., Ren Q., Wortman J., Huang J.,
RA   Goldman M.H., Goldman G.H.;
RT   "The ergosterol biosynthesis pathway, transporter genes, and azole
RT   resistance in Aspergillus fumigatus.";
RL   Med. Mycol. 43:S313-S319(2005).
RN   [3]
RP   FUNCTION.
RX   PubMed=18191972; DOI=10.1016/j.steroids.2007.11.005;
RA   Alcazar-Fuoli L., Mellado E., Garcia-Effron G., Lopez J.F., Grimalt J.O.,
RA   Cuenca-Estrella J.M., Rodriguez-Tudela J.L.;
RT   "Ergosterol biosynthesis pathway in Aspergillus fumigatus.";
RL   Steroids 73:339-347(2008).
RN   [4]
RP   FUNCTION, DISRUPTION PHENOTYPE, SUBCELLULAR LOCATION, INDUCTION,
RP   BIOTECHNOLOGY, AND PATHWAY.
RX   PubMed=27986720; DOI=10.1128/aem.02924-16;
RA   Long N., Xu X., Zeng Q., Sang H., Lu L.;
RT   "Erg4A and Erg4B are required for conidiation and azole resistance via
RT   regulation of ergosterol biosynthesis in Aspergillus fumigatus.";
RL   Appl. Environ. Microbiol. 83:0-0(2017).
CC   -!- FUNCTION: Delta(24(24(1)))-sterol reductase; part of the third module
CC       of ergosterol biosynthesis pathway that includes the late steps of the
CC       pathway (PubMed:27986720). Catalyzes the last step of ergosterol
CC       biosynthesis by converting ergosta-5,7,22,24(28)-tetraen-3beta-ol into
CC       ergosterol (PubMed:27986720). The third module or late pathway involves
CC       the ergosterol synthesis itself through consecutive reactions that
CC       mainly occur in the endoplasmic reticulum (ER) membrane. Firstly, the
CC       squalene synthase erg9 catalyzes the condensation of 2 farnesyl
CC       pyrophosphate moieties to form squalene, which is the precursor of all
CC       steroids. Squalene synthase is crucial for balancing the incorporation
CC       of farnesyl diphosphate (FPP) into sterol and nonsterol isoprene
CC       synthesis. Secondly, squalene is converted into lanosterol by the
CC       consecutive action of the squalene epoxidase erg1 and the lanosterol
CC       synthase erg7. Then, the delta(24)-sterol C-methyltransferase erg6
CC       methylates lanosterol at C-24 to produce eburicol. Eburicol is the
CC       substrate of the sterol 14-alpha demethylase encoded by cyp51A and
CC       cyp51B, to yield 4,4,24-trimethyl ergosta-8,14,24(28)-trienol. The C-14
CC       reductase erg24 then reduces the C14=C15 double bond which leads to
CC       4,4-dimethylfecosterol. A sequence of further demethylations at C-4,
CC       involving the C-4 demethylation complex containing the C-4 methylsterol
CC       oxidases erg25A or erg25B, the sterol-4-alpha-carboxylate 3-
CC       dehydrogenase erg26 and the 3-keto-steroid reductase erg27, leads to
CC       the production of fecosterol via 4-methylfecosterol. The C-8 sterol
CC       isomerase erg2 then catalyzes the reaction which results in
CC       unsaturation at C-7 in the B ring of sterols and thus converts
CC       fecosterol to episterol. The sterol-C5-desaturase erg3B then catalyzes
CC       the introduction of a C-5 double bond in the B ring to produce 5-
CC       dehydroepisterol. The 2 other sterol-C5-desaturases, erg3A and erg3C,
CC       seem to be less important in ergosterol biosynthesis. The C-22 sterol
CC       desaturase erg5 further converts 5-dehydroepisterol into ergosta-
CC       5,7,22,24(28)-tetraen-3beta-ol by forming the C-22(23) double bond in
CC       the sterol side chain. Finally, ergosta-5,7,22,24(28)-tetraen-3beta-ol
CC       is substrate of the C-24(28) sterol reductases erg4A and erg4B to
CC       produce ergosterol. Possible alternative sterol biosynthetic pathways
CC       might exist from fecosterol to ergosterol, depending on the activities
CC       of the erg3 isoforms (PubMed:16110826, PubMed:18191972) (Probable).
CC       {ECO:0000269|PubMed:27986720, ECO:0000305|PubMed:16110826,
CC       ECO:0000305|PubMed:18191972}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ergosterol + NADP(+) = ergosta-5,7,22,24(28)-tetraen-3beta-ol
CC         + H(+) + NADPH; Xref=Rhea:RHEA:18501, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16933, ChEBI:CHEBI:18249, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.3.1.71;
CC         Evidence={ECO:0000305|PubMed:27986720};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:18503;
CC         Evidence={ECO:0000305|PubMed:27986720};
CC   -!- PATHWAY: Steroid metabolism; ergosterol biosynthesis.
CC       {ECO:0000305|PubMed:16110826}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:27986720}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- INDUCTION: Expression is induced in the absence of erg4A.
CC       {ECO:0000269|PubMed:27986720}.
CC   -!- DISRUPTION PHENOTYPE: Deletion of both erg4A and erg4B results in
CC       fluffy colonies with severely impaired conidiation and increased
CC       susceptibility to antifungal azoles itraconazole and voriconazole, but
CC       does not affect virulence (PubMed:27986720). The double deletion leads
CC       also to the loss of ergosterol production and accumulation of the
CC       ergosta-5,7,22,24(28)-tetraenol precursor (PubMed:27986720).
CC       {ECO:0000269|PubMed:27986720}.
CC   -!- BIOTECHNOLOGY: Inhibition of erg4A and erg4B might be an effective
CC       approach for alleviating A.fumigatus infection.
CC       {ECO:0000269|PubMed:27986720}.
CC   -!- MISCELLANEOUS: In Aspergillus, the biosynthesis pathway of the sterol
CC       precursors leading to the prevalent sterol ergosterol differs from
CC       yeast. The ring system of lanosterol in S.cerevisiae is firstly
CC       demethylised in three enzymatic steps leading to the intermediate
CC       zymosterol and secondly a methyl group is added to zymosterol by the
CC       sterol 24-C-methyltransferase to form fecosterol. In Aspergillus,
CC       lanosterol is firstly transmethylated by the sterol 24-C-
CC       methyltransferase leading to the intermediate eburicol and secondly
CC       demethylated in three steps to form fecosterol.
CC       {ECO:0000305|PubMed:18191972}.
CC   -!- SIMILARITY: Belongs to the ERG4/ERG24 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AAHF01000003; EAL91183.1; -; Genomic_DNA.
DR   RefSeq; XP_753221.1; XM_748128.1.
DR   STRING; 746128.CADAFUBP00006063; -.
DR   EnsemblFungi; EAL91183; EAL91183; AFUA_5G14350.
DR   GeneID; 3511014; -.
DR   KEGG; afm:AFUA_5G14350; -.
DR   VEuPathDB; FungiDB:Afu5g14350; -.
DR   eggNOG; KOG1435; Eukaryota.
DR   HOGENOM; CLU_015631_3_1_1; -.
DR   InParanoid; Q4WW43; -.
DR   OMA; TVMIIHR; -.
DR   OrthoDB; 532774at2759; -.
DR   UniPathway; UPA00768; -.
DR   Proteomes; UP000002530; Chromosome 5.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0000246; F:delta24(24-1) sterol reductase activity; IBA:GO_Central.
DR   GO; GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IBA:GO_Central.
DR   GO; GO:0006696; P:ergosterol biosynthetic process; IBA:GO_Central.
DR   GO; GO:0016126; P:sterol biosynthetic process; IBA:GO_Central.
DR   InterPro; IPR001171; ERG24_DHCR-like.
DR   InterPro; IPR018083; Sterol_reductase_CS.
DR   Pfam; PF01222; ERG4_ERG24; 1.
DR   PROSITE; PS01017; STEROL_REDUCT_1; 1.
PE   1: Evidence at protein level;
KW   Endoplasmic reticulum; Glycoprotein; Lipid biosynthesis; Lipid metabolism;
KW   Membrane; NADP; Oxidoreductase; Reference proteome; Steroid biosynthesis;
KW   Steroid metabolism; Sterol biosynthesis; Sterol metabolism; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..471
FT                   /note="Delta(24(24(1)))-sterol reductase erg4A"
FT                   /id="PRO_0000454120"
FT   TRANSMEM        33..53
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        89..109
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        130..150
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        159..179
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        216..236
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        244..264
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        282..302
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        313..333
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        397..417
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   BINDING         340
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:G4SW86"
FT   BINDING         344
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:G4SW86"
FT   BINDING         380
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:G4SW86"
FT   BINDING         392..393
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:G4SW86"
FT   BINDING         432
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:G4SW86"
FT   BINDING         436..440
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:G4SW86"
FT   BINDING         447
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:G4SW86"
FT   CARBOHYD        15
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
SQ   SEQUENCE   471 AA;  54516 MW;  560D4AA6F7DFA752 CRC64;
     MKSKMAAKDQ KRLDNASSSD TKIEFEFGGA PGVTLIMIGF PLLMYYMYIG AVLYDGLLPT
     PEDGQSWADF LSHLVSLAYT HAYPTRKAWT IYWTFLILEG AGYLYLPGVY GKGKRLPHLG
     GKQLPYYCSA VSSWYLTIAA ALILHFTGVL KLYTLIDEFG PLMSVAICSG IFVSIVAYIS
     ALVRGVEHRM TGSHVYDFFM GAELNPRLFG WLDFKMFFEV RIPWFILFLL TLGTALKQLE
     EYGLVAGEVL FLLMAHFLYA NACAKGEELI ITSWDMYYEK WGFMLIFWNL AGVPMSYCHC
     TLYLAYHDPS TYHWNPWVLA VWAVAYLFMY WVWDTCNSQK NYFRAQERGV TVDRKTFPQL
     PWKYIENPQS IPTKTGDSIL CSGWFGMARK VHYTCDVFFA ISWGLITGFN SPFPWFYPCF
     FTVMIIHRAR RDINRCRERY GEAWMEYERR VPYLFIPVSF ADLPHKDKLT D
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024